What is Cytek Biosciences, Inc.'s net investment in lease?

Cytek Biosciences, Inc. (CTKB) reported net investment in lease of $10.64M in Q1 2026.

How has Cytek Biosciences, Inc.'s net investment in lease changed year-over-year?

Cytek Biosciences, Inc.'s net investment in lease increased by 7.8% year-over-year, from $9.87M to $10.64M.

What is the long-term trend for Cytek Biosciences, Inc.'s net investment in lease?

Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s net investment in lease has grown at a -6.2% compound annual growth rate (CAGR), from $14.6M to $11.32M.

Cytek Biosciences, Inc. CTKB Net Investment in Lease

Net Investment in Lease at other companies

DanaherDHR

——

10x Genomics, Inc.TXG

——

TEC

Bio-TechneTECH

——

RevvityRVTY

——

Agilent TechnologiesA

——

Bio-Rad LaboratoriesBIO

——

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s net investment in lease?: Cytek Biosciences, Inc. (CTKB) reported net investment in lease of $10.64M in Q1 2026.
How has Cytek Biosciences, Inc.'s net investment in lease changed year-over-year?: Cytek Biosciences, Inc.'s net investment in lease increased by 7.8% year-over-year, from $9.87M to $10.64M.
What is the long-term trend for Cytek Biosciences, Inc.'s net investment in lease?: Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s net investment in lease has grown at a -6.2% compound annual growth rate (CAGR), from $14.6M to $11.32M.